Modeling time-varying efficacy of RTS,S/AS01 malaria vaccine across trial settings

npj Vaccines · Published 2026-07-03 · DOI 10.1038/s41541-026-01519-4

Free full text

Authors (3)

Ziwei Zhao, Paul Milligan, Yin Bun Cheung

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhao, Z., Milligan, P., Cheung, Y. (2026). Modeling time-varying efficacy of RTS,S/AS01 malaria vaccine across trial settings. npj Vaccines. https://doi.org/10.1038/s41541-026-01519-4

Related articles

• Maturation-deficient chikungunya virus elicits protective immune responses in a murine challenge model · npj Vaccines · 2026 · Same journal
• Recent advances in Epstein–Barr virus vaccines development from mechanistic exploration to clinical translation · npj Vaccines · 2026 · Same journal
• Maternal influenza vaccination boosts durable breast milk antibody-mediated protection in infants · npj Vaccines · 2026 · Same journal
• Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities · npj Vaccines · 2026 · Same journal
• Preserved SARS-CoV-2 T-cell responses despite impaired humoral immunity in children with profound B-cell lymphopenia · npj Vaccines · 2026 · Same journal
• Suppressor tRNA-mediated conditionally replicating live vaccine effectively protects pigs against Seneca Valley virus challenge · npj Vaccines · 2026 · Same journal
• Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy · npj Vaccines · 2026 · Same journal
• Post-exposure vaccination with an adjuvanted protein subunit vaccine, but not BCG, protects mice and guinea pigs against M. tuberculosis · npj Vaccines · 2026 · Same journal
• Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis · npj Vaccines · 2026 · Same journal
• Safety and immunogenicity testing of a melioidosis subunit vaccine candidate in cynomolgus macaques · npj Vaccines · 2026 · Same journal